Qube Research & Technologies (QRT)
ESPR

Qube Research & Technologies (QRT)’s Esperion Therapeutics ESPR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$570K Buy
+208,161
New +$659K ﹤0.01% 2693
2025
Q3 		– Sell
-485,603
Closed -$478K – 3717
2025
Q2 		$478K Buy
485,603
+342,067
+238% +$343K ﹤0.01% 2709
2025
Q1 		$207K Sell
143,536
-85,194
-37% -$157K ﹤0.01% 2855
2024
Q4 		$503K Sell
228,730
-522,054
-70% -$1.22M ﹤0.01% 2474
2024
Q3 		$1.24M Sell
750,784
-351,864
-32% -$710K ﹤0.01% 1951
2024
Q2 		$2.45M Sell
1,102,648
-504,664
-31% -$1.19M ﹤0.01% 1536
2024
Q1 		$4.31M Buy
1,607,312
+1,172,071
+269% +$2.85M 0.01% 1322
2023
Q4 		$1.3M Buy
435,241
+403,679
+1,279% +$524K ﹤0.01% 1771
2023
Q3 		$30.9K Sell
31,562
-92,419
-75% -$134K ﹤0.01% 3009
2023
Q2 		$172K Buy
123,981
+78,848
+175% +$110K ﹤0.01% 1819
2023
Q1 		$71.8K Buy
+45,133
New +$233K ﹤0.01% 2180

Other funds holding ESPR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return